Document Detail

Omeprazole versus famotidine in the healing and relapse of duodenal ulcer.
MedLine Citation:
PMID:  8218758     Owner:  NLM     Status:  MEDLINE    
Sixty patients with symptomatic duodenal ulcer were randomized to receive either omeprazole (20 mg each morning) or famotidine (40 mg at night time) for 2-4 weeks in a double-blind parallel group clinical trial. Healing rates were higher with omeprazole in comparison with famotidine after 2 weeks (77% vs. 40%, P < 0.001) and 4 weeks (93% vs. 80%, P = 0.2) of treatment. Assessment of daily diary cards completed by all patients revealed that omeprazole rapidly relieved ulcer-related day pain and nocturnal pain in comparison to famotidine. Treatment with omeprazole for 2 weeks was also associated with lower cumulative antacid intake (P < 0.05) and reduced absenteeism from work. Helicobacter pylori infection was present in all patients and remained unaffected by treatment with either of the drugs. None of the drugs produced any significant adverse effects. During 6 months follow-up of all the patients after ulcer healing (without maintenance therapy), ulcer relapse was seen in 40% of omeprazole- and 37% of famotidine-treated patients (P > 0.1). The duration of ulcer-free period following initial healing of ulcer was also similar in both the groups (median time: 22 weeks for omeprazole, 21 weeks for famotidine). We conclude that omeprazole is superior to famotidine in rapidly healing duodenal ulcers and achieving more rapid pain relief, but does not influence subsequent ulcer relapse.
S C Misra; S Dasarathy; M P Sharma
Related Documents :
7565948 - A comparison of five maintenance therapies for reflux esophagitis.
7604138 - Nicergoline in senile dementia of alzheimer type and multi-infarct dementia: a double-b...
22632908 - The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen ...
361348 - Controlled trial of a carbenoxolone/alginate antacid combination in reflux oesophagitis.
1914298 - The effect of patient age, gender, and tibial component fixation on pain relief after c...
16950068 - Acetabular revision using a trabecular metal acetabular component for severe acetabular...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  7     ISSN:  0269-2813     ISO Abbreviation:  Aliment. Pharmacol. Ther.     Publication Date:  1993 Aug 
Date Detail:
Created Date:  1993-12-10     Completed Date:  1993-12-10     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  443-9     Citation Subset:  IM    
Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analgesics / therapeutic use
Antacids / administration & dosage
Double-Blind Method
Duodenal Ulcer / drug therapy*,  microbiology,  physiopathology
Famotidine / adverse effects,  therapeutic use*
Helicobacter Infections / diagnosis
Helicobacter pylori
Middle Aged
Omeprazole / adverse effects,  therapeutic use*
Pain / prevention & control
Wound Healing / drug effects*
Reg. No./Substance:
0/Analgesics; 0/Antacids; 73590-58-6/Omeprazole; 76824-35-6/Famotidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exocrine pancreatic secretion in man following one week of M1-muscarinic receptor blockade.
Next Document:  Comparison of two intravenous ranitidine regimens in a homogeneous population of intensive care unit...